Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin to Prevent Preeclampsia in High Risk Women
NCT03944512Phase 3Terminated
- Sponsor
- George Washington University Biostatistics Center
- Start
- Jul 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pravastatin in preeclampsia, sponsored by George Washington University Biostatistics Center. Started Jul 2019; status: terminated.
02
Drugs
pravastatin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT03944512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03944512.